In agreement with previous studies on the conditional Braf mutant melanoma model (40), the solvent control animals developed darkly pigmented spot lesions about 1 week after induction and they reached the humane end-point 4 weeks later due to an aggressive melanoma growth (Figure 1B, Supplementary Figure S1A, B). Here, BRAF is linked to melanoma.